Recombinant multi-species BIRC1/ NAIP/ NLRB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The target: NAIP, gene name: NAIP, also named as BIRC1, NLRB1, psiNAIP. This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. This copy of the gene is full length; additional copies with truncations and internal deletions are also present in this region of chromosome 5q13. It is thought that this gene is a modifier of spinal muscular atrophy caused by mutations in a neighboring gene, SMN1. The protein encoded by this gene contains regions of homology to two baculovirus inhibitor of apoptosis proteins, and it is able to suppress apoptosis induced by various signals. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Nov 2016].
Order information
* GeneMedi provides NON-PROFIT PRICE to support Academic research.Please click inquiry for product quotation. → Inquiry
Catalog No. | Product Name | Species | Size | Price |
GM-Tg-hg-TA165-Ag-1 | Human NAIP protein | Human | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-rg-TA165-Ag-1 | Rat NAIP protein | Rat | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-mg-TA165-Ag-1 | Mouse NAIP protein | Mouse | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-cynog-TA165-Ag-1 | Cynomolgus/ Rhesus macaque NAIP protein | Cynomolgus/ Rhesus macaque | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-felg-TA165-Ag-1 | Feline NAIP protein | Feline | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-cang-TA165-Ag-1 | Canine NAIP protein | Canine | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-bovg-TA165-Ag-1 | Bovine NAIP protein | Bovine | 1mg/10mg/100mg/≥100mg | Inquiry |
GM-Tg-bovg-TA165-Ag-1 | Equine NAIP protein | Equine | 1mg/10mg/100mg/≥100mg | Inquiry |
Shipping Cost: | 760.00 |
Description
Catalog No. | GM-Tg-hg-TA165-Ag, GM-Tg-rg-TA165-Ag, GM-Tg-mg-TA165-Ag, GM-Tg-cynog-TA165-Ag, GM-Tg-felg-TA165-Ag, GM-Tg-cang-TA165-Ag, GM-Tg-bovg-TA165-Ag, GM-Tg-equg-TA165-Ag-1 |
Products Name | NAIP protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | NAIP |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NAIP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
